Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 8:37 AM ET

Pharmaceuticals

Company Overview of Quintessence Biosciences, Inc.

Company Overview

Quintessence Biosciences, Inc., a biopharmaceutical company, develops novel protein-based therapeutics as anti-cancer agents. The company’s products include Evade RNase QBI-139 that causes tumor growth inhibition in breast, colorectal, non-small cell lung, ovarian, pancreatic, and prostate cancers; targeted EVade ribonucleases, a tumor targeting therapy; and EVade ribonuclease zymogens that are inactive enzyme precursors that proteolytically cleave to manifest their catalytic activity. Its products are based on the Evade ribonuclease technology that allows for the engineering of human proteins (ribonucleases) for the treatment of human diseases. The company was founded in 2000 and is based i...

505 South Rosa Road

Madison, WI 53719

United States

Founded in 2000

Phone:

608-441-2950

Fax:

608-441-2952

Key Executives for Quintessence Biosciences, Inc.

Chairman of the Board, Chief Executive Officer and Member of Business Board
Chairman of the Scientific Advisory Board, President and Chief Operating Officer
Founder, Member of Business Board, Director and Member of the Scientific Advisory Board
Founder, Member of Business Board, Director and Member of the Scientific Advisory Board
Member of Business Board
Compensation as of Fiscal Year 2015.

Quintessence Biosciences, Inc. Key Developments

Quintessence Biosciences, Inc. Presents at Mid-America Healthcare Venture Forum, Mar-10-2015 10:40 AM

Quintessence Biosciences, Inc. Presents at Mid-America Healthcare Venture Forum, Mar-10-2015 10:40 AM. Venue: Fairmont Chicago, Millennium Park, 200 North Columbus Drive, Chicago, IL 60601, United States. Speakers: Laura E. Strong, Chairman of the Scientific Advisory Board, President and Chief Operating Officer.

Quintessence Biosciences, Inc. Presents at Mid America Healthcare Venture Forum, Mar-10-2015 10:40 AM

Quintessence Biosciences, Inc. Presents at Mid America Healthcare Venture Forum, Mar-10-2015 10:40 AM. Venue: Fairmont Chicago, Chicago, Illinois, United States. Speakers: Laura E. Strong, Chairman of the Scientific Advisory Board, President and Chief Operating Officer.

Quintessence Biosciences, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014

Quintessence Biosciences, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.

Similar Private Companies By Industry

Company Name Region
GMP Laboratories of America, Inc. United States
Shasun Pharma Solutions Inc. United States
Chakshu Research, Inc. United States
Ceptaris Therapeutics, Inc. United States
Eisai Corporation of North America, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Quintessence Biosciences, Inc., please visit www.quintbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.